These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38702281)

  • 1. Resection of colorectal carcinoma liver metastases: A population-based study in outcomes and factors associated with recurrent disease.
    Fenwick A; Black C; Linehan V; Gala-Lopez BL; Costa AF
    Curr Probl Diagn Radiol; 2024; 53(4):481-487. PubMed ID: 38702281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage RFA in patients with intrahepatic recurrence after major hepatic surgery for colorectal cancer liver metastases: mid-term outcome.
    Zimmermann M; Pedersoli F; Schulze-Hagen M; Lurje G; Isfort P; Kuhl C; Bruners P
    Eur Radiol; 2020 Feb; 30(2):1221-1227. PubMed ID: 31493210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
    Simpson AL; Doussot A; Creasy JM; Adams LB; Allen PJ; DeMatteo RP; Gönen M; Kemeny NE; Kingham TP; Shia J; Jarnagin WR; Do RKG; D'Angelica MI
    Ann Surg Oncol; 2017 Sep; 24(9):2482-2490. PubMed ID: 28560599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
    Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
    Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy delivery for resected colorectal cancer liver metastases: Management and outcomes in routine clinical practice.
    Krishnamurthy A; Kankesan J; Wei X; Nanji S; Biagi JJ; Booth CM
    Eur J Surg Oncol; 2017 Feb; 43(2):364-371. PubMed ID: 27727025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
    Reddy SK; Tsung A; Marsh JW; Geller DA
    J Surg Oncol; 2012 Jan; 105(1):55-9. PubMed ID: 21842519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
    Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
    Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.
    Chok KS; Cheung TT; Chan AC; Dai WC; Chan SC; Fan ST; Poon RT; Lo CM
    ANZ J Surg; 2014; 84(7-8):545-9. PubMed ID: 23809019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological analysis of recurrence patterns and prognostic factors for survival after hepatectomy for colorectal liver metastasis.
    Hayashi M; Inoue Y; Komeda K; Shimizu T; Asakuma M; Hirokawa F; Miyamoto Y; Okuda J; Takeshita A; Shibayama Y; Tanigawa N
    BMC Surg; 2010 Sep; 10():27. PubMed ID: 20875094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional lymph node involvement in patients undergoing liver resection for colorectal cancer metastases.
    Nanji S; Tsang ME; Wei X; Booth CM
    Eur J Surg Oncol; 2017 Feb; 43(2):322-329. PubMed ID: 28057391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of recurrence after a first hepatectomy for colorectal cancer liver metastases: a retrospective analysis.
    Bredt LC; Rachid AF
    World J Surg Oncol; 2014 Dec; 12():391. PubMed ID: 25528650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of recurrence timing and tumor burden score on overall survival among patients undergoing repeat hepatectomy for colorectal liver metastases.
    Endo Y; Rueda BO; Woldesenbet S; Munir MM; Lima HA; Katayama ES; Shaikh CF; Guglielmi A; Ruzzenente A; Aldrighetti L; Alexandrescu S; Kitago M; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Surg Oncol; 2023 Sep; 128(4):560-568. PubMed ID: 37195231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases.
    Zhai Y; Bai W; Zhou J; Dong Q; Zhang J
    BMC Cancer; 2022 Jan; 22(1):103. PubMed ID: 35078439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron Emission Tomography Combined With Computed Tomography vs. No Positron Emission Tomography Combined With Computed Tomography for the Management of Patients With Resectable Colorectal Cancer Liver Metastases and Synchronous Extrahepatic Disease.
    Serrano PE; Gu CS; Moulton CA; Gallinger S
    Am Surg; 2021 Sep; 87(9):1431-1437. PubMed ID: 33345573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.
    Knowles B; Welsh FK; Chandrakumaran K; John TG; Rees M
    HPB (Oxford); 2012 May; 14(5):298-309. PubMed ID: 22487067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat Hepatectomy After Major Hepatectomy for Colorectal Liver Metastases.
    Takamoto T; Hashimoto T; Miyata A; Shimada K; Maruyama Y; Makuuchi M
    J Gastrointest Surg; 2020 Feb; 24(2):380-387. PubMed ID: 30830515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.